Global Kinetics Corporation

What Global Kinetics Corporation does

Global Kinetics Corporation is a private Australian medical technology company founded in 2007 and headquartered in Melbourne, with disclosed ties to researchers at the Florey Neuroscience Institute. Across three documented funding rounds between 2015 and 2018, the company raised approximately $20.8 million in aggregate, with Brandon Capital serving as lead investor on the two largest rounds ($13.3M Series 2 in June 2015 and $6.0M in April 2018). The company operates with a 11–50 employee headcount and has built a dedicated China Business Unit — a structurally significant internationalization bet for a firm of this size, with the China General Manager role combined into the COO seat.

Leadership is composed of CEO Zach Henderson, Co-Founder Malcolm Horne, Chief Operating Officer and General Manager of the China Business Unit Brooke Ren, and Contract General Counsel and Compliance Officer Kathryn Meintsma. No management beyond these four roles is disclosed, and no partners, customers, distributors, or product references are documented in the available source material. The Neuroscience Institute research lineage and the company name ("Kinetics") together suggest a movement/neurology orientation, but specific products, indications, regulatory clearances, pricing, and revenue mechanics cannot be characterized from the supplied data.

Business model mechanics, GTM channels, customer segments, and revenue figures are not disclosed in the input. The firm's corporate domain (globalkineticscorporation.com) is currently suspended due to non-completion of an ICANN-mandated contact verification, which materially limits public visibility into the business but is not on its own dispositive of operational status. Net of the available evidence, the company reads as a venture-backed clinical/medical-technology entity with neuroscience research roots and an early Asia-Pacific commercial footprint, with its current scale and momentum unverifiable from the provided sources.

Name

Global Kinetics Corporation

Website

https://globalkineticscorporation.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Global Kinetics Corporation is a private Australian medical technology company founded in 2007 in Melbourne, with research ties to the Florey Neuroscience Institute and a dedicated China Business Unit, backed by Brandon Capital-led venture funding.

Ownership category

akta.pro rank

Product category

Neurological Monitoring Devices

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Regulatory Operations & Publishing (eCTD, RIM, Submission Management) (HLAGAKAC)

akta.pro secondary industry

Technical Committees, Working Groups & Expert Panels (BPADANAB)

Keywords

• Neuroscience research
• Medical technology
• Clinical research tools
• Brain disorder monitoring
• Wearable medical devices

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Core offering

Global Kinetics Corporation collaborates with researchers from the Florey Neuroscience Institute, indicating work in neuroscience-related medical technology. The firm is headquartered in Melbourne, Australia, operates as a private for-profit entity founded in 2007, and has 11-50 employees. Specific product and service offerings are not documented in the available source data because the firm's website is currently suspended for non-completion of an ICANN-mandated contact verification.

Product overview

Unable to extract product and service information. The company's website (globalkineticscorporation.com) is currently suspended due to non-completion of an ICANN-mandated contact verification process. The available source content consists solely of a domain suspension page and an empty legal page, which do not contain any product, service, or business offering information.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves4 records

Expansion highlights3 records

Direct peers

• Great Lakes NeuroTechnologies: Developer of the Kinesia and Kinesia-ONE wearable sensor systems for objective measurement of Parkinson's disease motor symptoms. Directly comparable as a wearable, sensor-based Parkinson's assessment technology serving clinicians and clinical trials.
• Rune Labs: Maker of StrivePD, a Parkinson's monitoring platform combining a wearable (Apple Watch) with cloud analytics to track tremor, dyskinesia and medication response. Direct peer in objective, wearable Parkinson's measurement targeting clinical and research use.
• iRhythm Technologies: Public wearable cardiac-monitoring company (Zio patch) that combines a regulated wearable device with algorithmic analysis delivered to clinicians. Closely comparable business model of regulated wearable diagnostic paired with data-services revenue.
• Empatica: Maker of the Embrace wearable and EpiMonitor for neurological conditions, FDA-cleared for seizure monitoring. Comparable as a regulated wearable neurological-monitoring company pairing a sensor with proprietary analytics.
• ActiGraph: Provider of clinical-grade wearable actigraphy sensors and analytics used extensively in CNS clinical trials. Comparable as a wearable activity/kinematics measurement platform serving pharma and academic research.
• Cleveland Medical Devices / CleveMed: Developer of Kinesia HomeView and other wearable sensors for remote motor assessment in Parkinson's and other movement disorders. Direct peer in home-based, wearable Parkinson's motor monitoring.

Broad incumbents

• Medtronic: Broad incumbent in neurological devices, including deep brain stimulation systems for advanced Parkinson's disease. Comparable as an established medtech player operating in the same Parkinson-care continuum.
• AbbVie: Markets Duopa and other Parkinson's therapies, making it both a potential pharma partner and a broad incumbent whose treatment paradigm any Parkinson wearable will need to integrate with.

Emerging players

• MC10 / BioIntellisense: Developer of flexible, skin-like wearable sensors for continuous clinical-grade vital sign and movement monitoring. Adjacent emerging player in regulated wearable biosensors with overlapping kinematics technology stack.
• Psyonic: Emerging player in advanced mobility/kinetic sensing and assistive robotics for neurological conditions. Thematically overlapping in objective motion/kinetics measurement for neurological patient populations.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks4 records

Key highlights5 records

Customer concentration

• Xx.com/kinetics_corp

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Global Kinetics Corporation